Clinical Trial Update: Active Control of Prostatic Cancer With Criteria of Latence

View source ↗

Summary

The clinical trial 'Active Control of Prostatic Cancer With Criteria of Latence' has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Clinique Mutualiste Chirurgicale de la Loire | Conditions: Prostate Cancer | Status: TERMINATED